• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Perkinelmer

research test tube pipette laboratory clinical trial study science
MedTech

PerkinElmer picks up Covaris’ sample prep portfolio

New Mountain bought the lab supply business and brand from PerkinElmer in March via a $2.45 billion deal, and is now combining it with Covaris.
Conor Hale Dec 4, 2023 11:23am
stage curtains

Revvity revamps imaging offerings with launch of 4 scanners

Sep 5, 2023 1:58pm
Gene editing gene therapy CRISPR

AstraZeneca taps Revvity's gene editing tech for cell therapies

May 18, 2023 9:45am
Revvity logo PerkinElmer

PerkinElmer rebrands slimmed-down medtech business as Revvity

May 9, 2023 8:00am
PerkinElmer HQ

PerkinElmer completes $2.45B split into 2 separate companies

Mar 14, 2023 12:13pm
Blood sample microscope study clinical trial lab research

PerkinElmer to sell off 3 units for $2.45B, reclaim Dx focus

Aug 2, 2022 12:57pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings